FCCC LOGO Faculty Publications
Jordan VC
Optimising endocrine approaches for the chemoprevention of breast cancer - Beyond the Study of Tamoxifen and Raloxifene (STAR) Trial
European Journal of Cancer. 2006 Nov;42(17) :2909-2913
PMID: ISI:000242686100019   
Back to previous list
Abstract
The completion of the Study of Tamoxifen and Raloxifene (STAR) [Vogel VG, Costantino JP, Wickerham DL, et al. The Study of Tamoxifen and Raloxifene (STAR): Report of the National Surgical Adjuvant Breast and Bowel Project P-2 Trial. JAMA 2006;295:2727-2741.] and the ongoing studies with aromatase inhibitors [Goss PE. Breast cancer prevention-clinical trials strategies involving aromatase inhibitors. J Steroid Biochem Mol Biol 2003;86(3-5):487-93.] to assess their worth for the chemoprevention of breast cancer, creates an opportunity to consider the realistic future for chemoprevention as an option for women's healthcare and to identify strategies for future progress in an era of targeted therapeutics, managed healthcare and soaring costs. (c) 2006 Published by Elsevier Ltd.
Notes
ISI Document Delivery No.: 114SO Times Cited: 0 Cited Reference Count: 30 Cited References: *EBCTCG, 1998, LANCET, V351, P1451 BANKS E, 2003, LANCET, V362, P419 BARRETTCONNOR E, 2006, NEW ENGL J MED, V355, P125 COOMBES RC, 2004, NEW ENGL J MED, V350, P1081 CUMMINGS SR, 1999, JAMA-J AM MED ASSOC, V281, P2189 FISHER B, 1998, J NATL CANCER I, V90, P1371 GAIL MH, 1989, J NATL CANCER I, V81, P1879 GAIL MH, 1999, J NATL CANCER I, V91, P1829 GOSS PE, 2003, J STEROID BIOCHEM, V86, P487 GOSS PE, 2005, J NATL CANCER I, V97, P1262 GOTTARDIS MM, 1987, CANCER RES, V47, P4020 HERSHMAN D, 2002, J CLIN ONCOL, V20, P9 HOWELL A, 2005, LANCET, V365, P60 JORDAN VC, 1983, BREAST CANC RES TR S, V3, S73 JORDAN VC, 1983, ENDOCRINOLOGY, V113, P463 JORDAN VC, 1987, BREAST CANCER RES TR, V10, P31 JORDAN VC, 1988, CANCER INVEST, V6, P589 JORDAN VC, 2001, CANCER RES, V61, P5683 LACASSAGNE A, 1936, AM J CANCER, V27, P217 LERNER LJ, 1990, CANCER RES, V50, P4177 LOVE RR, 1991, ANN INTERN MED, V115, P860 LOVE RR, 1992, NEW ENGL J MED, V326, P852 MARTINO S, 2004, J NATL CANCER I, V96, P1751 MELNIKOW J, 2006, CANCER ROCKHILL B, 2001, J NATL CANCER I, V93, P358 ROSSOUW JE, 2002, JAMA-J AM MED ASSOC, V288, P321 SNYDER KR, 2000, AM J HEALTH-SYST PH, V57, P1669 SUH N, 2002, CLIN CANCER RES, V8, P3270 THURLIMANN B, 2005, NEW ENGL J MED, V353, P2747 VOGEL VG, 2006, JAMA-J AM MED ASSOC, V295, P2727